Disclosures for "Efficacy and Safety of Eculizumab in Refractory Myasthenia Gravis: A Meta-analysis and Systematic Review"
-
Dr. Najeeb has nothing to disclose.
-
Ms. Koppanatham has nothing to disclose.
-
Dr. AMIR has nothing to disclose.
-
Dr. Butt has nothing to disclose.
-
Dr. Moazzam has nothing to disclose.
-
Miss Ijaz has nothing to disclose.
-
Dr. Mohamed has nothing to disclose.
-
Dr. Omer has nothing to disclose.
-
Miss Azhar has nothing to disclose.
-
Dr. Kanu has nothing to disclose.
-
Dr. Niraula has nothing to disclose.